Gossamer Bio (GOSS) Financials

$0.18

$0.01 (3.77%)

As on 08-Sep-2026 12:38EDT

Market cap

$86 Mln

Revenue (TTM)

$53 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	53.29	48.47	114.70	--	--	--
Cost of Revenue	0.46	1.00	4.15	4.39	4.43	5.17
Gross Profit	53.05	47.47	114.70	-4.39	-4.43	-5.17
Operating Expenses	219.15	210.72	174.62	183.76	218.59	216.12
Operating Profit (EBIT)	-166.09	-163.25	-59.92	-183.76	-218.59	-216.12
Other Income	--	--	--	--	3.10	1.56
Profit before Tax	-125.31	-170.46	-55.64	-179.82	-229.38	-234.00
Provision for Tax	-0.09	-0.09	0.89	10.00	10.85	15.07
Profit after Tax (Net Income)	-125.22	-170.37	-56.53	-179.82	-229.38	-234.00
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-229.38	-234.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-94.03	-122.76	29.49	62.77	12.08	121.46
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	33.11	231.57	240.79	197.55	211.14	182.34
Current Liabilities	137.78	63.44	45.01	51.60	49.23	39.86
Total Liabilities	214.65	172.25	315.29	311.92	272.45	343.66

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	4.14	4.61	5.40	5.40	10.57	11.88
Current Assets	72.73	167.64	309.89	306.52	261.88	331.78
Total Assets	214.65	172.25	315.29	311.92	272.45	343.66
Total Debt*	39.10	202.91	202.88	212.46	225.74	185.24
Net Current Assets	-65.06	104.21	264.88	254.92	212.65	291.92

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-171.27	-3.47	-159.16	-187.03	-188.89
Cash Flow from Investing Activities	--	156.36	29.02	-110.97	-1.04	-117.43
Cash from Financing Activities	--	6.43	-11.49	190.15	117.09	3.33
Net Cash Inflow / Outflow	--	--	--	--	-70.98	-302.99

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.55	-0.75	-0.25	-0.80	-2.43	-3.10
Cash EPS ($)	--	-0.75	-0.23	-0.78	-2.39	-3.03
Adjusted Book Value ($)	--	--	0.13	0.28	0.13	1.61
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.76	-0.02	-0.71	-1.98	-2.50
Free Cash Flow per Share ($)	--	-0.76	-0.02	-0.71	-1.99	-2.52

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-109.03	-22.27	-70.10	-84.25	-57.70
ROE (%)	--	365.33	-122.54	-480.50	-343.53	-105.85
ROA (%)	-49.19	-69.89	-18.03	-61.54	-74.46	-53.00
EBIT Margin (%)	-386.02	-329.00	-38.46	--	--	--
Net Margin (%)	-235.00	-351.49	-49.28	--	-7,411.24	-15,000.26
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	32.43	-0.58	--	--	--	--
EBIT Growth (%)	-56.63	-261.46	73.47	22.83	-0.44	6.99
Net Profit Growth (%)	9.74	-201.39	68.56	21.61	1.98	3.84
EPS Growth (%)	10.57	-2.01	0.69	0.67	0.21	0.07
Book Value Growth (%)	-97.96	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.12	-3.63	-1.14	-0.89	-3.65
Price / Book Value	2.66	-5.72	6.95	3.28	16.94	7.04
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.39	-4.85	-2.84	-0.75	-0.83	-3.41
Close Price ($)	0.16	3.10	0.90	0.91	2.17	11.31
High Price ($)	3.87	3.87	1.60	3.06	15.20	14.30
Low Price ($)	0.14	0.76	0.50	0.45	1.57	7.04
Market Cap ($ Cr)	85.69	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.65	6.88	3.38	18.69	1.53
Short term debt to equity ratio	-0.38	-0.01	0.03	0.24	1.21	0.02
Current Ratio	0.53	2.64	6.88	5.94	5.32	8.32
Quick Ratio	0.53	--	--	--	--	8.33
Interest Coverage	-10.43	-14.51	-3.83	-12.31	-15.53	-11.04

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.45	25.84	4.65	--	--	--
Asset Turnover	0.21	0.20	0.37	--	--	--
Receivable days	--	67.31	17.00	--	--	--
Inventory Days	--	--	--	--	-11.22	8.09
Payable days	--	1,508.75	345.14	290.91	193.92	380.02
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.